Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium glycerophosphate is an inorganic-organic phosphate salt used primarily as a **phosphate replacement and alkalinizing agent** rather than a targeted molecular therapeutic. It dissociates to provide phosphate and potassium, supporting phosphate repletion and cellular phosphate-dependent metabolism, including ATP generation and buffering functions. Public-source evidence confirms its existence in the biomedical literature, including older publications describing its use as a biochemical medium component and as a preservative for rat liver nuclei, but the provided context does not support a modern sponsor-specific clinical development program, brand, or proprietary manufacturer for this exact substance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium glycerophosphate.